SAGE (Sage Therapeutics, Inc.) Projected Sales Volume

sagerx.com - graphic logo of issuer SAGE

Sage Therapeutics, Inc. (SAGE) does not pay dividends, focusing instead on its status as an innovator in the mental health sector. The company's future sales volume serves as an indicator of market confidence, with 0.07 recorded as the baseline value. Sage Therapeutics, Inc. (SAGE) leads in CNS therapy, developing rapid-acting medications for postpartum depression. Portfolio optimization has reduced costs, although financial stability currently relies on the commercial success of new products.

Company Future Revenue: Sage Therapeutics Inc (SAGE) for 07/04/2022 - 08/16/2025

Sage Therapeutics, Inc - analytical breakdowns and key metrics (SAGE)

Analysis of all company metrics:sagerx.com SAGE
Signature product of Sage Therapeutics Inc.

This indicator aggregates daily market expectations for future revenue, capturing the vector of consolidated participant rates. The metric allows for an assessment of the issuer's fundamental stability through the lens of expected cash flow. By analyzing the projected sales volume, an investor determines the market's level of confidence in the company's commercial success. For Sage Therapeutics, Inc. (SAGE), this is critical due to the slow adoption of antidepressants. This chart's price action reveals risks of budget deficits for the promotion of new drugs.

Analysis of competing companies

Company Future Sales Volume BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Company Future Revenue|Company Projected Revenue Regencell RGC|Company Projected Revenue Volume AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Projected Sales Volume|XENE - Projected Sales Volume|VKTX: Projected Sales Volume|Company Expected Revenue SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Projected Sales Volume|DNLI: Company Future Revenue|Company Projected Revenue harmonybiosciences.com (HRMY)|Biohaven - Company Revenue Forecast|Projected Sales Volume AMLX (amylyx.com)|Trevi Pharma (TRVI) - Company Expected Sales Volume|Praxis Corp - Projected Sales Volume|Anavex Corp (AVXL) - Company Future Sales Volume|CBLL: Projected Sales Volume|Prothena Biosciences - Company Future Revenue|ALEC (alector.com) - Projected Sales Volume|Company Revenue Forecast ANNX (Annexon Biosciences)|Company Projected Revenue Omeros Corporation (OMER)|Neurogene Corp - Company Revenue Forecast|Company Projected Revenue AC Immune S.A. ACIU|Company Future Sales Voyager Therapeutics (VYGR)|Neumora - Projected Sales Volume|Company Expected Revenue SCLX|Tevogen Bio Inc. (TVGN) - Company Projected Revenue|Company Revenue Forecast ACOG|CGTX (cogrx.com) - Projected Sales Volume|Company Future Sales Volume inhibikase.com (IKT)|Company Projected Revenue Cassava Sciences Inc (SAVA)|Company Future Sales Assertio|Projected Sales Volume COYA (Coya Therapeutics, Inc.)|Company Projected Revenue Volume VTGN (VistaGen Therapeutics Inc)|OVID: Company Future Sales Volume|ABOS: Company Projected Revenue|CervoMed (CRVO) - Company Projected Revenue|Company Expected Sales Volume Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Projected Sales Volume|Company Revenue Forecast PEPG (PepGen)|Company Future Sales Volume JUNS (Jupiter Neurosciences, Inc.)|Projected Sales Volume relmada.com (RLMD)|Company Projected Revenue Annovis Bio Corp ANVS|GRCE: Company Revenue Forecast|AIFF - Company Projected Revenue|KLTO (anewmeds.com) - Company Revenue Forecast|NRSN (NeuroSense Therapeutics Ltd.) - Company Future Sales Volume|revivapharma.com - Company Future Revenue|MTVA (metaviatx.com) - Projected Sales Volume|NRXS: Company Future Revenue|Projected Sales Volume HSDT|PASG - Company Expected Sales Volume|Projected Sales Volume NEUP (Neuphoria Therapeutics)|NERV: Company Revenue Forecast|ATHA: Company Future Sales Volume|Addex Therapeutics Ltd - Company Projected Revenue Volume|Alzamend Neuro, Inc. (ALZN) - Company Projected Revenue|CYCN (Cyclerion Therapeutics Inc.) - Company Projected Revenue|Company Future Sales Volume PTIX|KTTA: Company Future Revenue|Company Future Sales Volume CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Company Future Revenue|Company Projected Revenue Brainstorm Cell Therapeutics, Inc. BCLI|Company Future Revenue CARA|chromocell.com - Projected Sales Volume|Company Expected Revenue ELYM|ITCI: Projected Sales Volume|Company Expected Sales Volume Longboard Pharmaceuticals, Inc. (LBPH)|Company Projected Revenue Marinus Pharmaceuticals, Inc.|NKGN: Company Future Revenue|Projected Sales Volume NRBO|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics